Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$148.07M
Total Bought
$41.63M
Total Sold
$3.76M
Net Transaction
+$37.87M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
OCULIS HOLDING AG1,595,9181,737,696+141,77819,56629,54119.95%+9,975
ARCUTIS BIOTHERAPEUTICS INC(ARQT)2,120,5082,120,508019,72129,53919.95%+9,818
RECURSION PHARMACEUTICALS IN(RXRX)0595,518+595,51804,0262.72%+4,026
IO BIOTECH INC864,197864,19709077950.54%-112
BOLT BIOTHERAPEUTICS INC1,891,4671,891,46701,2261,0210.69%-204
RALLYBIO CORP2,404,6442,404,64402,8132,3081.56%-505
VIGIL NEUROSCIENCE INC560,595560,59501,9069530.64%-953
EXSCIENTIA PLC770,5000-770,5003,7600-3,760
ZENAS BIOPHARMA INC(ZBIO)650,695736,645+85,95011,0106,0334.07%-4,977
BIOAGE LABS INC(BIOA)527,647653,374+125,72710,9753,7832.55%-7,192
INOZYME PHARMA INC4,494,8514,494,851023,50812,4518.41%-11,057
VAXCYTE INC(PCVX)639,539703,834+64,29573,08057,61638.91%-15,464
Page 1 of 1